Department of Medical Physiology, Texas A&M College of Medicine, College Station, TX, USA.
Br J Pharmacol. 2019 Jun;176(12):1978-1988. doi: 10.1111/bph.14370. Epub 2018 Jun 25.
Activated immune cell infiltration into organs contributes to the development and maintenance of hypertension. Studies targeting specific immune cell populations or reducing their inflammatory signalling have demonstrated a reduction in BP. Lymphatic vessels play a key role in immune cell trafficking and in resolving inflammation, but little is known about their role in hypertension. Studies from our laboratory and others suggest that inflammation-associated or induction of lymphangiogenesis is organ protective and anti-hypertensive. This review provides the basis for hypertension as a disease of chronic inflammation in various tissues and highlights how renal lymphangiogenesis is a novel regulator of kidney health and BP. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.
免疫细胞浸润到器官中会导致高血压的发生和维持。针对特定免疫细胞群或减少其炎症信号的研究表明,血压会降低。淋巴管在免疫细胞运输和炎症解决中起着关键作用,但它们在高血压中的作用知之甚少。我们实验室和其他实验室的研究表明,与炎症相关或诱导淋巴管生成具有器官保护和抗高血压作用。这篇综述为高血压作为各种组织中慢性炎症的一种疾病提供了依据,并强调了肾脏淋巴管生成如何成为肾脏健康和血压的新调节因子。
本文是免疫靶点在高血压中的一个专题部分的一部分。要查看该部分的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.